Electromed (ELMD) Stock Price, News & Analysis

Company Overview

Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as well as neuromuscular conditions, such as cerebral palsy and amyotrophic lateral sclerosis; SmartVest SQL System; SmartVest Clearway System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall; and SmartVest Connect, a wireless technology that allows data connection between physicians and patients to track therapy performance and collaborate in treatment decisions. It also provides single patient use SmartVest and SmartVest Wrap products for health care providers in the acute care setting. The company offers its products to hospitals, home health care centers, pulmonary rehabilitation centers, cystic fibrosis centers, neuromuscular clinics, and other clinics through distributors. It markets its products to physicians, health care providers, and directly to patients. Electromed, Inc. was incorporated in 1992 and is headquartered in New Prague, Minnesota.

Key Stats

• Today's Range: $34.34 to $35.54
• 50-Day Range: $27.00 to $35.43
• 52-Week Range: $9.90 to $35.56
• Volume: 66,138 shs
• Average Volume: 81,787 shs
• Market Capitalization: $291.02 million
• P/E Ratio: 47.78
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

ELMD Stock Analysis - Frequently Asked Questions

How have ELMD shares performed this year?

Electromed's stock was trading at $29.55 at the beginning of the year. Since then, ELMD shares have increased by 16.4% and is now trading at $34.40.
View the best growth stocks for 2025 here.

How were Electromed's earnings last quarter?

Electromed, Inc. (NYSE:ELMD) announced its quarterly earnings data on Tuesday, November, 12th. The company reported $0.16 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.03 by $0.13. The company had revenue of $14.67 million for the quarter. Electromed had a net margin of 11.34% and a trailing twelve-month return on equity of 15.32%.

Who are Electromed's major shareholders?

Electromed's top institutional shareholders include White Pine Capital LLC (0.37%), Ellsworth Advisors LLC (0.29%), Ritholtz Wealth Management (0.20%) and Wilmington Savings Fund Society FSB (0.11%). Insiders that own company stock include Andrew Summers and Kathleen Skarvan.
View institutional ownership trends.

How do I buy shares of Electromed?

Shares of ELMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Electromed own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Electromed investors own include NVIDIA (NVDA), Enterprise Products Partners (EPD), Energy Transfer (ET), Meta Platforms (META), Pfizer (PFE), TransEnterix (TRXDW) and Avino Silver & Gold Mines (ASM).

Company Calendar

• Last Earnings: 11/12/2024
• Today: 2/01/2025
• Fiscal Year End: 6/30/2025

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Medical
• Industry: Electromedical equipment
• Sub-Industry: Medical Equipment
• Current Symbol: NYSE:ELMD
• CUSIP: N/A
• CIK: 1488917
• Web: smartvest.com
• Phone: (952) 758-9299
• Fax: 866-758-5077
• Employees: 160
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): $0.72
• Trailing P/E Ratio: 47.78
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $5.15 million
• Net Margins: 11.34%
• Pretax Margin: 15.69%
• Return on Equity: 15.32%
• Return on Assets: 13.13%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 5.53
• Quick Ratio: 5.06

Sales & Book Value

• Annual Sales: $54.72 million
• Price / Sales: 5.32
• Cash Flow: $0.67 per share
• Price / Cash Flow: 51.19
• Book Value: $5.15 per share
• Price / Book: 6.68

Miscellaneous

• Outstanding Shares: 8,460,000
• Free Float: 7,274,000
• Market Cap: $291.02 million
• Optionable: Optionable
• Beta: 0.31